191 related articles for article (PubMed ID: 36301443)
1. Dextromethorphan/Bupropion: First Approval.
Keam SJ
CNS Drugs; 2022 Nov; 36(11):1229-1238. PubMed ID: 36301443
[TBL] [Abstract][Full Text] [Related]
2. Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity.
Stahl SM
CNS Spectr; 2019 Oct; 24(5):461-466. PubMed ID: 31566163
[TBL] [Abstract][Full Text] [Related]
3. Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence.
Parincu Z; Iosifescu DV
Expert Rev Neurother; 2023 Mar; 23(3):205-212. PubMed ID: 36943010
[TBL] [Abstract][Full Text] [Related]
4. New Combination Drug for Depression.
Aschenbrenner DS
Am J Nurs; 2023 Apr; 123(4):24-25. PubMed ID: 36951340
[TBL] [Abstract][Full Text] [Related]
5. Treatment Resistant Depression with Loss of Antidepressant Response: Rapid-Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging Molecule.
Lauterbach EC
Psychopharmacol Bull; 2016 Aug; 46(2):53-58. PubMed ID: 27738380
[TBL] [Abstract][Full Text] [Related]
6. Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder.
Willett KC; Bond LR; Morrill AM; Lorena D; Petru I
Am J Ther; 2024 Jan-Feb 01; 31(1):e24-e29. PubMed ID: 38231578
[TBL] [Abstract][Full Text] [Related]
7. Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder.
McCarthy B; Bunn H; Santalucia M; Wilmouth C; Muzyk A; Smith CM
Clin Psychopharmacol Neurosci; 2023 Nov; 21(4):609-616. PubMed ID: 37859435
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials.
Majeed A; Xiong J; Teopiz KM; Ng J; Ho R; Rosenblat JD; Phan L; Cao B; McIntyre RS
Expert Opin Emerg Drugs; 2021 Mar; 26(1):63-74. PubMed ID: 33682569
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI).
Iosifescu DV; Jones A; O'Gorman C; Streicher C; Feliz S; Fava M; Tabuteau H
J Clin Psychiatry; 2022 May; 83(4):. PubMed ID: 35649167
[No Abstract] [Full Text] [Related]
10. Dextromethorphan: From Cough Suppressant to Antidepressant.
Kverno K
J Psychosoc Nurs Ment Health Serv; 2022 Nov; 60(11):9-11. PubMed ID: 36317836
[TBL] [Abstract][Full Text] [Related]
11. Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial.
Tabuteau H; Jones A; Anderson A; Jacobson M; Iosifescu DV
Am J Psychiatry; 2022 Jul; 179(7):490-499. PubMed ID: 35582785
[TBL] [Abstract][Full Text] [Related]
12. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
Lauterbach EC
Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
[TBL] [Abstract][Full Text] [Related]
13. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials.
Akbar D; Rhee TG; Ceban F; Ho R; Teopiz KM; Cao B; Subramaniapillai M; Kwan ATH; Rosenblat JD; McIntyre RS
CNS Drugs; 2023 Oct; 37(10):867-881. PubMed ID: 37792265
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice.
Saavedra JS; Garrett PI; Honeycutt SC; Peterson AM; White JW; Hillhouse TM
Pharmacol Biochem Behav; 2020 Oct; 197():173003. PubMed ID: 32755625
[TBL] [Abstract][Full Text] [Related]
15. Dextromethorphan as a potential rapid-acting antidepressant.
Lauterbach EC
Med Hypotheses; 2011 May; 76(5):717-9. PubMed ID: 21367535
[TBL] [Abstract][Full Text] [Related]
16. The role of NMDA receptor and nitric oxide/cyclic guanosine monophosphate pathway in the antidepressant-like effect of dextromethorphan in mice forced swimming test and tail suspension test.
Sakhaee E; Ostadhadi S; Khan MI; Yousefi F; Norouzi-Javidan A; Akbarian R; Chamanara M; Zolfaghari S; Dehpour AR
Biomed Pharmacother; 2017 Jan; 85():627-634. PubMed ID: 27908707
[TBL] [Abstract][Full Text] [Related]
17. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
18. Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.
Murrough JW; Wade E; Sayed S; Ahle G; Kiraly DD; Welch A; Collins KA; Soleimani L; Iosifescu DV; Charney DS
J Affect Disord; 2017 Aug; 218():277-283. PubMed ID: 28478356
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CYP2D6 activity by bupropion.
Kotlyar M; Brauer LH; Tracy TS; Hatsukami DK; Harris J; Bronars CA; Adson DE
J Clin Psychopharmacol; 2005 Jun; 25(3):226-9. PubMed ID: 15876900
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?
Schatzberg AF
Am J Psychiatry; 2022 Jul; 179(7):448-450. PubMed ID: 35775155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
